FONR Stock Forecast 2025-2026
Distance to FONR Price Targets
FONR Price Momentum
🤔 Considering FONAR (FONR)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Latest FONR Stock Price Targets & Analyst Predictions
FONR has shown a year-to-date change of -8.7% and a 1-year change of -36.9%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for FONR. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
FONR Analyst Ratings
FONR Price Target Range
Latest FONR Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for FONR.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Fonar Corporation (FONR) Competitors
The following stocks are similar to FONAR based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Fonar Corporation (FONR) Financial Data
Fonar Corporation has a market capitalization of $87.50M with a P/E ratio of 12.0x. The company generates $101.57M in trailing twelve-month revenue with a 7.7% profit margin.
Revenue growth is -1.7% quarter-over-quarter, while maintaining an operating margin of +9.8% and return on equity of +6.5%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Fonar Corporation (FONR) Business Model
About Fonar Corporation
Develops advanced MRI scanners and imaging equipment.
Fonar Corporation generates revenue by developing and manufacturing innovative Magnetic Resonance Imaging (MRI) scanners and related medical imaging equipment for healthcare providers. Its unique products, such as the UPRIGHT Multi-Position MRI and Fonar 360 toroidal scanner, allow for enhanced diagnostic capabilities, which hospitals and diagnostic centers purchase to improve patient care.
Founded in 1978, Fonar Corporation was a pioneer in MRI technology, creating the first MRI scanner. Based in Melville, New York, the company emphasizes research and development to advance medical imaging technology, positioning itself as a key player in the healthcare sector.
Company Information
Sector
Healthcare
Industry
Diagnostics & Research
Employees
520
CEO
Mr. Timothy R. Damadian M.D.
Country
United States
IPO Year
1993
Website
www.fonar.comFonar Corporation (FONR) Latest News & Analysis
FONAR's Q2 fiscal 2025 revenues and net income decreased due to increased costs and reduced scan volumes.
FONAR's declining revenues and net income signal potential financial instability, raising concerns about profitability and future growth, which may impact stock performance.
MRI scan volume at HMCA managed sites rose 7% to 79,207 for the six months ending December 31, 2024, while owned sites saw a 4% decline to 26,961 scans during the same period.
Increased MRI scans at HMCA managed sites indicate growth and potential revenue expansion, while the decline at owned sites may raise concerns about operational efficiency and profitability.
FONAR: Assets Remain Too Cheap To Pass Up
3 months agoFONAR has minimal debt and positive profitability, with a low P/B ratio of 0.61. Despite a decline in Q1 earnings, book value is growing due to strategic investments. Risks include low trading volume and market reactions.
FONAR shows potential with low debt and growing book value, making it attractive despite recent earnings declines and risks. Strong financials may limit downside, appealing to value-focused investors.
HMCA reported a 5% increase in total MRI scans to 53,054 for Q3 2024. Cash and cash equivalents decreased 4% to $54.2 million as of September 30, 2024.
Increased MRI scan volume signals growing demand and potential revenue growth, while the cash decline may raise concerns about liquidity and operational efficiency.
FONAR's fiscal Q1 earnings show decreased revenues and income due to lower patient fees and rising costs, despite a modest increase in MRI scan volume.
FONAR's declining revenues and income signal potential financial instability, while modest MRI scan growth may not offset rising costs, impacting future profitability and investment attractiveness.
FONAR's fiscal 2024 top line growth is driven by strong revenue performance in its HMCA segment.
FONAR's revenue growth in the HMCA segment indicates strong demand and operational performance, potentially boosting investor confidence and stock value.
Frequently Asked Questions About FONR Stock
What is Fonar Corporation's (FONR) stock forecast for 2025?
Analyst forecasts for Fonar Corporation (FONR) are not currently available. The stock is trading at $13.82.
Is FONR stock a good investment in 2025?
Analyst ratings for FONR are not currently available. The stock is currently trading at $13.82. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for FONR stock?
Price predictions from Wall Street analysts for FONR are not currently available. The stock is trading at $13.82.
What is Fonar Corporation's business model?
Fonar Corporation generates revenue by developing and manufacturing innovative Magnetic Resonance Imaging (MRI) scanners and related medical imaging equipment for healthcare providers. Its unique products, such as the UPRIGHT Multi-Position MRI and Fonar 360 toroidal scanner, allow for enhanced diagnostic capabilities, which hospitals and diagnostic centers purchase to improve patient care.
What is the highest forecasted price for FONR Fonar Corporation?
Price targets from Wall Street analysts for FONR are not currently available. The stock is trading at $13.82.
What is the lowest forecasted price for FONR Fonar Corporation?
Price targets from Wall Street analysts for FONR are not currently available. The stock is trading at $13.82.
What is the overall FONR consensus from analysts for Fonar Corporation?
Analyst ratings for FONR are not currently available. The stock is trading at $13.82.
How accurate are FONR stock price projections?
Stock price projections, including those for Fonar Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
